EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Small Molecule Insulin Sensitisers: New Leads and Targets for Next-Generation Insulin Sensitising Strategies

Chong-Yew Lee

Medicinal Chemistry Research · 2026

DOI: 10.1007/s00044-026-03577-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicinal Chemistry Research, 2026. Verfasst von Chong-Yew Lee. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Penang, 11800, Malaysia. chongyew@usm.my. Hauptthemen laut MEDLINE: Insulin, Diabetes Mellitus, Type 2, Hypoglycemic Agents, Small Molecule Libraries. Die Arbeit nennt 138 Literaturangaben. Gefördert von: Ministry of Higher Education, Malaysia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 diabetes (T2D) is a major global health problem driven largely by insulin resistance, the impaired cellular response to insulin. Few current therapies directly address this underlying cause. Thiazolidinediones, potent peroxisome proliferator-activated receptor gamma (PPARγ) agonists, remain the only true small-molecule insulin sensitisers, but their clinical use is limited by adverse effects associated with non-selective activation of this target. Consequently, research has shifted toward alternative pathways that enhance insulin signalling without relying on PPARγ agonism. This review summarises advances from 2013 to 2025 in the development of novel small-molecule insulin sensitisers across diverse scaffolds and mechanisms. Structure-activity relationships, established and emerging molecular targets, and structural insights that inform rational drug design are highlighted. Selected leads were also evaluated using the BOILED-Egg model to assess oral drug-likeness and early "technology readiness." Overall, this review aims to inspire medicinal chemists by presenting promising leads and strategies for the development of next-generation insulin-sensitising therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InsulinDiabetes Mellitus, Type 2Hypoglycemic AgentsSmall Molecule LibrariesHumansAnimalsStructure-Activity RelationshipPPAR-gamma AgonistsPPAR gammaInsulin Resistance

Stichwörter der Autor:innen

Insulin sensitisersNovel mechanismsSmall moleculesStructure-activity relationships

Substanzen

InsulinHypoglycemic AgentsSmall Molecule LibrariesPPAR-gamma AgonistsPPAR gamma

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Penang, 11800, Malaysia. chongyew@usm.my.

Förderung

  • Ministry of Higher Education, Malaysia

Zitieren

APA

Lee, C. Y. (2026). Small Molecule Insulin Sensitisers: New Leads and Targets for Next-Generation Insulin Sensitising Strategies. Medicinal Chemistry Research. https://doi.org/10.1007/s00044-026-03577-8

Vancouver

Lee CY. Small Molecule Insulin Sensitisers: New Leads and Targets for Next-Generation Insulin Sensitising Strategies. Medicinal Chemistry Research. 2026. doi:10.1007/s00044-026-03577-8

BibTeX
@article{Lee2026,
  author = {Lee, Chong-Yew},
  title = {Small Molecule Insulin Sensitisers: New Leads and Targets for Next-Generation Insulin Sensitising Strategies},
  journal = {Medicinal Chemistry Research},
  year = {2026},
  doi = {10.1007/s00044-026-03577-8}
}
Kostenlos starten →